(Q43039375)

12 November 2017

title

High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma (English)

1 reference

12 November 2017

N Tanaka

1

1 reference

12 November 2017

T Chiba

2

1 reference

12 November 2017

Y Matsuzaki

3

1 reference

12 November 2017

T Osuga

4

1 reference

12 November 2017

T Aikawa

5

1 reference

12 November 2017

K Mitamura

6

1 reference

12 November 2017

language of work or name

1 reference

1 August 1993

1 reference

Gastroenterologia Japonica

12 November 2017

published in

1 reference

12 November 2017

volume

28

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

547-553

1 reference

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02776954

Non-specificity of anti-HCV test for seroepidemiological analysis

21 January 2018

1 reference

12 December 2020

Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan

1 reference

12 December 2020

Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide

1 reference

12 December 2020

Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region

1 reference

12 December 2020

Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02776954

1 reference

12 November 2017

1 reference